secwatch.observer — SEC 8-K summary
======================================

Issuer:     RESMED INC (RMD)
CIK:        0000943819
Form:       8-K
Filed at:   2026-04-30T23:59:59+00:00
Accession:  0001193125-26-197282
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ResMed CFO Brett Sandercock retires; Aaron Bloomer appointed successor
----------------------------------------------------------------------

- Brett Sandercock retires as CFO effective May 4, 2026; remains special advisor to CEO through Dec 2027.
- Aaron Bloomer appointed CFO effective May 4; previously CFO of Exact Sciences (recently acquired by Abbott).
- Bloomer compensation: $725k salary, $150k sign-on bonus, $3.3M equity grant (RSUs/PSUs with TSR metrics).
- Resmed reiterates FY2026 guidance: gross margin 62-63%, SG&A 19-20%, R&D 6-7%, tax rate 21-23%.
- Sandercock's retirement not due to any disagreement; retains salary, benefits and equity vesting through 2027.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/943819/000119312526197282/0001193125-26-197282-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/943819/000119312526197282/d50610d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-197282

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer